Composition for forming pluronic-based hydrogel with improved stability
View Patent ↗Disclosed is a composition for forming an injectable hydrogel. The composition includes 1% by weight or less of a graphene-based material and 5% by weight or more of a triblock copolymer. The triblock copolymer may be a copolymer represented by Formula 1: wherein n is an integer from 8 to 540, m is an integer from 16 to 70, and R is H or a vinylcarbonyl group (CH 2 ═CHCO—). When R in Formula 1 is a vinylcarbonyl group, the triblock copolymer may be crosslinked through the vinylcarbonyl group to form a nanogel. The composition can be prepared by a simple mixing process. In addition, the composition is substantially free from in vitro and in vivo stability problems encountered with conventional hydrogel compositions. Furthermore, the composition has high biocompatibility as well as excellent mechanical properties such as high storage modulus.
1. A composition for forming an injectable hydrogel, comprising
0.04% to about 0.9% by weight of a graphene-based material, wherein the graphene-based material comprises graphene oxide modified by substituting surface hydroxyl groups thereof with carboxyl groups; and
5% by weight or more of a triblock copolymer, wherein
(i) the triblock copolymer is a copolymer represented by Formula 1:
wherein n is an integer from 8 to 540, m is an integer from 16 to 70, and R is H or a vinylcarbonyl group (CH 2 ═CHCO—), or
(ii) the triblock copolymer is the copolymer of Formula 1 wherein R is a vinylcarbonyl group and is crosslinked through the vinylcarbonyl group to form a nanogel,
wherein a weight ratio of the graphene-based material to the triblock copolymer ranges from 0.04:17 to 0.1:17 when the triblock copolymer is the copolymer of (i), and
wherein the weight ratio of the graphene-based material and the triblock copolymer ranges from 0.04:11 to 0.1:11 when the triblock copolymer is the crosslinked nanogel of (ii).
2. The composition according to claim 1 , wherein, in Formula 1, R is H, n/2 is 100, and m is 65.
3. The composition according to claim 1 , wherein, in Formula 1, R is a vinylcarbonyl group, n/2 is 100, and m is 65.
4. The composition according to claim 1 , wherein the graphene-based material and the triblock copolymer are present in amounts ranging from 0.04% to about 0.9% by weight and 5 to 50% by weight, respectively.
5. The composition according to claim 1 , wherein the composition comprises at least one solvent selected from the group consisting of distilled water, buffers, and physiological saline.
6. A sustained-release drug carrier comprising (1) the composition according to claims 1 and (2) a protein drug.
7. The sustained-release drug carrier according to claim 6 , wherein the protein drug is a growth factor.
8. The composition according to claim 1 , wherein the graphene-based material comprises graphene oxide modified by substituting all surface hydroxyl groups thereof with carboxyl groups.